Risk of secondary stroke subsequent to restarting aspirin in chronic stroke patients suffering from traumatic brain injury in Taiwan

• Published in: Scientific reports Vol. 13; no. 1; pp. 8001 - 9
• Main Authors: Chou, Chu-Lin, Chung, Chi-Hsiang, Hsu, Yung-Ho, Wu, Chia-Chao, Sun, Chien-An, Chien, Wu-Chien, Tang, Shih-En, Fann, Li-Yun
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 17.05.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 631/154/1438; 692/699/375/1345; 692/699/375/1370; 692/699/375/534; Adult; Aspirin; Aspirin - adverse effects; Brain Damage, Chronic; Brain Injuries, Traumatic - complications; Brain Injuries, Traumatic - drug therapy; Cerebral infarction; Clopidogrel; Diabetes mellitus; Dipyridamole; Drug Therapy, Combination; Female; Hemorrhage; Hemorrhage - drug therapy; Hospitalization; Humanities and Social Sciences; Humans; Ischemia; Kidney diseases; Male; Mortality; multidisciplinary; Myocardial infarction; Platelet Aggregation Inhibitors - adverse effects; Science; Science (multidisciplinary); Stroke; Stroke - complications; Stroke - drug therapy; Stroke - epidemiology; Taiwan - epidemiology; Traumatic brain injury; Young Adult; Taiwan

Traumatic brain injury (TBI) is a silent epidemic that has been easily ignored. The safety and efficacy of restarting antiplatelet therapy after encountering traumatic brain injury (TBI) events remain a challenge. We explored the outcomes of restarting aspirin use on secondary stroke and mortality i...